A medication used to manage type 2 diabetes has been found effective in treating sleep apnea.
"This study marks a significant milestone in the treatment of OSA, offering a promising new therapeutic option that addresses both respiratory and metabolic complications," said study leader Dr. Atul Malhotra, director ofMore than 900 million people worldwide are believed to have OSA, and the 469 participants in this study were recruited from the United States and eight other countries. All were clinically) treatment, in which a machine maintains an open airway during sleep.
Over the course of one year, patients who used tirzepatide had a significant drop in breathing interruptions during sleep. Their improvement was much greater than that seen in the placebo group. Researchers said some patients might no longer needis better than treating either condition on its own. Researchers said the drug therapy improved other aspects related to OSA, such as improving weight. Some patients, however, had mild stomach issues.
For patients who hate wearing a CPAP mask over their nose and mouth when they go to bed, the findings could be welcome news., potentially transforming how we approach and treat this pervasive condition on a global scale," Malhotra said in a UC San Diego Health news release.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apneaA new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep. The research found that people who took tirzepatide reduced the number of episodes per hour in which their breathing slowed or stopped completely while they slept by about half to nearly 60%.
Read more »
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apneaA new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep.
Read more »
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apneaA new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep.
Read more »
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apneaA new study finds the popular obesity drug Zepbound may help treat sleep apnea, a dangerous disorder in which people struggle to breathe during sleep.
Read more »
GLP-1 Meds May Help Extremely Obese Qualify for Weight-Loss SurgeryTaking a cutting-edge weight-loss drug could help extremely obese patients drop enough pounds to be eligible for bariatric surgery, a new study shows.
Read more »
Johns Hopkins School of Medicine, East Baltimore Campus job with Johns Hopkins University Department of MedicinePost-doctoral position available to study novel strategies for treating genetic disorders. The strategies involve studying transporters and channel proteins involved in disease processes and mitigating changes that occur in heat shock proteins that affect protein processing.
Read more »